NHS

News

NICE says yes to Braftovi combination for colorectal cancer

Two months after rejecting Pierre Fabre’s Braftovi for a rare form of metastatic colorectal cancer (mCRC), NICE has changed its mind, and now says the drug can be funded by the NHS in Engla

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

(781)NIHR-2nd-Webinar-Image-16x9-Text-v3

Increasing patient engagement with UK clinical trials

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of researc

Views & Analysis

Bridging the gap between pharma and the NHS in MS

Janette Curlis is a Multiple Sclerosis Nurse Advisor (MSNA) at Biogen, helping to support the company’s Multiple Sclerosis (MS) field teams and developing patient and Healthcare Professiona

News

London's digital health accelerator programme selects 20 new...

DigitalHealth.London has announced the latest 20 small and medium sized businesses selected for its digital accelerator programme.

News

After NICE okay, Scots denied access to Vifor’s Veltassa

The Scottish Medicines Consortium (SMC) has ruled that there’s not enough evidence to support NHS funding of Vifor Pharma’s Veltassa for excess potassium in the blood (hyperkalaemia), even

Views & Analysis

Deep Dive: Digital Health Innovation 2020

Most of the digital health experts we spoke to for this issue of Deep Dive made one thing clear – no one can really say what the future holds for digital tech in the pharma and healthcare i

NICE says yes to Braftovi combination for colorectal cancer

Increasing patient engagement with UK clinical trials

Bridging the gap between pharma and the NHS in MS

London's digital health accelerator programme selects 20 new...

After NICE okay, Scots denied access to Vifor’s Veltassa

Deep Dive: Digital Health Innovation 2020

BridgeBio gains on phase 3 dwarfism data

How to meet your physicians where they are online

NHS

Editor's Picks